Eintrag weiter verarbeiten
The Effect of Young Age in Hormone Receptor Positive Breast Cancer
Gespeichert in:
| Zeitschriftentitel: | BioMed Research International |
|---|---|
| Personen und Körperschaften: | , , , , , , |
| In: | BioMed Research International, 2015, 2015, S. 1-6 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Hindawi Limited
|
| Schlagwörter: |
| author_facet |
Lee, Minna K. Varzi, Leo A. Chung, Debra U. Cao, Minh-an Gornbein, Jeffrey Apple, Sophia K. Chang, Helena R. Lee, Minna K. Varzi, Leo A. Chung, Debra U. Cao, Minh-an Gornbein, Jeffrey Apple, Sophia K. Chang, Helena R. |
|---|---|
| author |
Lee, Minna K. Varzi, Leo A. Chung, Debra U. Cao, Minh-an Gornbein, Jeffrey Apple, Sophia K. Chang, Helena R. |
| spellingShingle |
Lee, Minna K. Varzi, Leo A. Chung, Debra U. Cao, Minh-an Gornbein, Jeffrey Apple, Sophia K. Chang, Helena R. BioMed Research International The Effect of Young Age in Hormone Receptor Positive Breast Cancer General Immunology and Microbiology General Biochemistry, Genetics and Molecular Biology General Medicine |
| author_sort |
lee, minna k. |
| spelling |
Lee, Minna K. Varzi, Leo A. Chung, Debra U. Cao, Minh-an Gornbein, Jeffrey Apple, Sophia K. Chang, Helena R. 2314-6133 2314-6141 Hindawi Limited General Immunology and Microbiology General Biochemistry, Genetics and Molecular Biology General Medicine http://dx.doi.org/10.1155/2015/325715 <jats:p><jats:italic>Background</jats:italic>. Studies have shown that young breast cancer patients have more advanced disease and worse survival compared to older patients. Our objective was to study disease characteristics and survival in the subset of young women with hormone receptor positive (HR+) and HER2 negative (HER2−) cancer.<jats:italic>Methods</jats:italic>. We retrospectively analyzed HR+/HER2− breast cancer patients who underwent surgery at our institution between 2002 and 2010. We compared clinical characteristics, pathology, treatment, and recurrence-free survival between younger (≤40 years) and older (>40 years) patients.<jats:italic>Results</jats:italic>. Of 669 HR+/HER2− breast cancer cases, 54 (8.1%) patients were 40 years or younger. Younger patients had more luminal B subtype, high grade, poor differentiation, and increased lymphovascular invasion. Younger women were treated more often with mastectomy and adjuvant chemotherapy. Although the unadjusted recurrence-free survival at median 55-month follow-up was lower in younger women, adjusting for stage, there was no significant difference (90.7% versus 89.3%,<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.74</mml:mn></mml:math>) between groups.<jats:italic>Conclusion</jats:italic>. Younger patients with HR+/HER2− breast cancer had more advanced disease and more aggressive treatment than older patients. The unfavorable pathologic features suggest a biologically different tumor in young women. After adjusting for these factors, younger patients have a recurrence-free survival similar to older patients.</jats:p> The Effect of Young Age in Hormone Receptor Positive Breast Cancer BioMed Research International |
| doi_str_mv |
10.1155/2015/325715 |
| facet_avail |
Online Free |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE1LzMyNTcxNQ |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE1LzMyNTcxNQ |
| institution |
DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Rs1 DE-Pl11 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 |
| imprint |
Hindawi Limited, 2015 |
| imprint_str_mv |
Hindawi Limited, 2015 |
| issn |
2314-6133 2314-6141 |
| issn_str_mv |
2314-6133 2314-6141 |
| language |
English |
| mega_collection |
Hindawi Limited (CrossRef) |
| match_str |
lee2015theeffectofyoungageinhormonereceptorpositivebreastcancer |
| publishDateSort |
2015 |
| publisher |
Hindawi Limited |
| recordtype |
ai |
| record_format |
ai |
| series |
BioMed Research International |
| source_id |
49 |
| title |
The Effect of Young Age in Hormone Receptor Positive Breast Cancer |
| title_unstemmed |
The Effect of Young Age in Hormone Receptor Positive Breast Cancer |
| title_full |
The Effect of Young Age in Hormone Receptor Positive Breast Cancer |
| title_fullStr |
The Effect of Young Age in Hormone Receptor Positive Breast Cancer |
| title_full_unstemmed |
The Effect of Young Age in Hormone Receptor Positive Breast Cancer |
| title_short |
The Effect of Young Age in Hormone Receptor Positive Breast Cancer |
| title_sort |
the effect of young age in hormone receptor positive breast cancer |
| topic |
General Immunology and Microbiology General Biochemistry, Genetics and Molecular Biology General Medicine |
| url |
http://dx.doi.org/10.1155/2015/325715 |
| publishDate |
2015 |
| physical |
1-6 |
| description |
<jats:p><jats:italic>Background</jats:italic>. Studies have shown that young breast cancer patients have more advanced disease and worse survival compared to older patients. Our objective was to study disease characteristics and survival in the subset of young women with hormone receptor positive (HR+) and HER2 negative (HER2−) cancer.<jats:italic>Methods</jats:italic>. We retrospectively analyzed HR+/HER2− breast cancer patients who underwent surgery at our institution between 2002 and 2010. We compared clinical characteristics, pathology, treatment, and recurrence-free survival between younger (≤40 years) and older (>40 years) patients.<jats:italic>Results</jats:italic>. Of 669 HR+/HER2− breast cancer cases, 54 (8.1%) patients were 40 years or younger. Younger patients had more luminal B subtype, high grade, poor differentiation, and increased lymphovascular invasion. Younger women were treated more often with mastectomy and adjuvant chemotherapy. Although the unadjusted recurrence-free survival at median 55-month follow-up was lower in younger women, adjusting for stage, there was no significant difference (90.7% versus 89.3%,<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.74</mml:mn></mml:math>) between groups.<jats:italic>Conclusion</jats:italic>. Younger patients with HR+/HER2− breast cancer had more advanced disease and more aggressive treatment than older patients. The unfavorable pathologic features suggest a biologically different tumor in young women. After adjusting for these factors, younger patients have a recurrence-free survival similar to older patients.</jats:p> |
| container_start_page |
1 |
| container_title |
BioMed Research International |
| container_volume |
2015 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792332113730600960 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T13:50:54.251Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=The+Effect+of+Young+Age+in+Hormone+Receptor+Positive+Breast+Cancer&rft.date=2015-01-01&genre=article&issn=2314-6141&volume=2015&spage=1&epage=6&pages=1-6&jtitle=BioMed+Research+International&atitle=The+Effect+of+Young+Age+in+Hormone+Receptor+Positive+Breast+Cancer&aulast=Chang&aufirst=Helena+R.&rft_id=info%3Adoi%2F10.1155%2F2015%2F325715&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792332113730600960 |
| author | Lee, Minna K., Varzi, Leo A., Chung, Debra U., Cao, Minh-an, Gornbein, Jeffrey, Apple, Sophia K., Chang, Helena R. |
| author_facet | Lee, Minna K., Varzi, Leo A., Chung, Debra U., Cao, Minh-an, Gornbein, Jeffrey, Apple, Sophia K., Chang, Helena R., Lee, Minna K., Varzi, Leo A., Chung, Debra U., Cao, Minh-an, Gornbein, Jeffrey, Apple, Sophia K., Chang, Helena R. |
| author_sort | lee, minna k. |
| container_start_page | 1 |
| container_title | BioMed Research International |
| container_volume | 2015 |
| description | <jats:p><jats:italic>Background</jats:italic>. Studies have shown that young breast cancer patients have more advanced disease and worse survival compared to older patients. Our objective was to study disease characteristics and survival in the subset of young women with hormone receptor positive (HR+) and HER2 negative (HER2−) cancer.<jats:italic>Methods</jats:italic>. We retrospectively analyzed HR+/HER2− breast cancer patients who underwent surgery at our institution between 2002 and 2010. We compared clinical characteristics, pathology, treatment, and recurrence-free survival between younger (≤40 years) and older (>40 years) patients.<jats:italic>Results</jats:italic>. Of 669 HR+/HER2− breast cancer cases, 54 (8.1%) patients were 40 years or younger. Younger patients had more luminal B subtype, high grade, poor differentiation, and increased lymphovascular invasion. Younger women were treated more often with mastectomy and adjuvant chemotherapy. Although the unadjusted recurrence-free survival at median 55-month follow-up was lower in younger women, adjusting for stage, there was no significant difference (90.7% versus 89.3%,<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.74</mml:mn></mml:math>) between groups.<jats:italic>Conclusion</jats:italic>. Younger patients with HR+/HER2− breast cancer had more advanced disease and more aggressive treatment than older patients. The unfavorable pathologic features suggest a biologically different tumor in young women. After adjusting for these factors, younger patients have a recurrence-free survival similar to older patients.</jats:p> |
| doi_str_mv | 10.1155/2015/325715 |
| facet_avail | Online, Free |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE1LzMyNTcxNQ |
| imprint | Hindawi Limited, 2015 |
| imprint_str_mv | Hindawi Limited, 2015 |
| institution | DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3 |
| issn | 2314-6133, 2314-6141 |
| issn_str_mv | 2314-6133, 2314-6141 |
| language | English |
| last_indexed | 2024-03-01T13:50:54.251Z |
| match_str | lee2015theeffectofyoungageinhormonereceptorpositivebreastcancer |
| mega_collection | Hindawi Limited (CrossRef) |
| physical | 1-6 |
| publishDate | 2015 |
| publishDateSort | 2015 |
| publisher | Hindawi Limited |
| record_format | ai |
| recordtype | ai |
| series | BioMed Research International |
| source_id | 49 |
| spelling | Lee, Minna K. Varzi, Leo A. Chung, Debra U. Cao, Minh-an Gornbein, Jeffrey Apple, Sophia K. Chang, Helena R. 2314-6133 2314-6141 Hindawi Limited General Immunology and Microbiology General Biochemistry, Genetics and Molecular Biology General Medicine http://dx.doi.org/10.1155/2015/325715 <jats:p><jats:italic>Background</jats:italic>. Studies have shown that young breast cancer patients have more advanced disease and worse survival compared to older patients. Our objective was to study disease characteristics and survival in the subset of young women with hormone receptor positive (HR+) and HER2 negative (HER2−) cancer.<jats:italic>Methods</jats:italic>. We retrospectively analyzed HR+/HER2− breast cancer patients who underwent surgery at our institution between 2002 and 2010. We compared clinical characteristics, pathology, treatment, and recurrence-free survival between younger (≤40 years) and older (>40 years) patients.<jats:italic>Results</jats:italic>. Of 669 HR+/HER2− breast cancer cases, 54 (8.1%) patients were 40 years or younger. Younger patients had more luminal B subtype, high grade, poor differentiation, and increased lymphovascular invasion. Younger women were treated more often with mastectomy and adjuvant chemotherapy. Although the unadjusted recurrence-free survival at median 55-month follow-up was lower in younger women, adjusting for stage, there was no significant difference (90.7% versus 89.3%,<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.74</mml:mn></mml:math>) between groups.<jats:italic>Conclusion</jats:italic>. Younger patients with HR+/HER2− breast cancer had more advanced disease and more aggressive treatment than older patients. The unfavorable pathologic features suggest a biologically different tumor in young women. After adjusting for these factors, younger patients have a recurrence-free survival similar to older patients.</jats:p> The Effect of Young Age in Hormone Receptor Positive Breast Cancer BioMed Research International |
| spellingShingle | Lee, Minna K., Varzi, Leo A., Chung, Debra U., Cao, Minh-an, Gornbein, Jeffrey, Apple, Sophia K., Chang, Helena R., BioMed Research International, The Effect of Young Age in Hormone Receptor Positive Breast Cancer, General Immunology and Microbiology, General Biochemistry, Genetics and Molecular Biology, General Medicine |
| title | The Effect of Young Age in Hormone Receptor Positive Breast Cancer |
| title_full | The Effect of Young Age in Hormone Receptor Positive Breast Cancer |
| title_fullStr | The Effect of Young Age in Hormone Receptor Positive Breast Cancer |
| title_full_unstemmed | The Effect of Young Age in Hormone Receptor Positive Breast Cancer |
| title_short | The Effect of Young Age in Hormone Receptor Positive Breast Cancer |
| title_sort | the effect of young age in hormone receptor positive breast cancer |
| title_unstemmed | The Effect of Young Age in Hormone Receptor Positive Breast Cancer |
| topic | General Immunology and Microbiology, General Biochemistry, Genetics and Molecular Biology, General Medicine |
| url | http://dx.doi.org/10.1155/2015/325715 |